Bilirubin
Cytochrome C
Gastric Mucin
HCG
FSH
UTI
PMSG
Aprotinin
Asparaginase
Beta Glucanase
Bromelain
Chymotrypsin
Kallikrein
Lysozyme
Pancreatin
Papain
Pepsin
Streptokinase
Trypsin
Urokinase
Coenzyme A
Coenzyme A Trilithium
Coenzyme Q10
Beta Glucans
Chitosan
Chondroitin Sulfate
Dextran
Dextran Sulfate Sodium
Glucosamine HCl
Heparin Sodium
Heparinoid
Hyaluronic Acid
Rosemary Extract
Sodium Cholate
Bilirubin
Cytochrome C
Gastric Mucin
HCG
FSH
UTI
PMSG
Aprotinin
Asparaginase
Beta Glucanase
Bromelain
Chymotrypsin
Kallikrein
Lysozyme
Pancreatin
Papain
Pepsin
Streptokinase
Trypsin
Urokinase
Coenzyme A
Coenzyme A Trilithium
Coenzyme Q10
Beta Glucans
Chitosan
Chondroitin Sulfate
Dextran
Dextran Sulfate Sodium
Glucosamine HCl
Heparin Sodium
Heparinoid
Hyaluronic Acid
Rosemary Extract
Sodium Cholate
Jiagen Biotechnologies
Proteins

Gastric Mucin

CAS No:84082-64-4 9016-61-3
EINECS No:232-738-1
EC No:282-010-7
Synonyms:Gastric mucus, gastric mucus glycoprotein, gastric surface mucin, glycoprotein mucin, hog gastric mucin, MUC5AC (predominant mucin subtype in gastric mucus), mucin from porcine gastric mucosa, mucin from porcine stomach, PGM, stomach mucin

Product Summary

Gastric mucin is a high-molecular-weight glycoprotein primarily responsible for forming the protective mucus barrier in the stomach. It is a complex molecule with extensive glycosylation that grants it viscoelastic, adhesive, and pathogen-trapping properties. In scientific research, gastric mucin is widely used to model the gastrointestinal mucus layer for drug delivery studies, pathogen adhesion analysis, and the development of mucoadhesive biomaterials. It is sensitive to moisture and temperature, thus requiring cold and dry storage conditions. Its versatile biological and biophysical properties make it a critical component in gastroenterology, microbiology, and pharmaceutical research.

Function

Gastric mucin’s unique structure directly enables several protective and regulatory actions:

  • Primary physical barrier: Gastric mucin forms a continuous, viscous gel layer coating the entire gastric epithelium, which physically separates the delicate epithelial cells from the harsh luminal environment including stomach acid (pH ~1.5–3.5), digestive enzymes, abrasive food particles, pathogens). The dense glycocalyx and mucus gel impedes pepsin diffusion towards the epithelium, preventing autodigestion.
  • Pathogens defense: The sticky gel physically traps bacteria, viruses, and other pathogens, preventing them from adhering to and invading the epithelium. Specific glycan structure on mucin can acts as receptor decoys, binding to pathogens (like H. Pylori), preventing epithelial attachment.
  • Lubrication: Reduces friction during stomach churning, preventing mechanical damage.
  • Selective permeability: While acting as a barrier to large molecules, pathogens, and acid, it allows the passage of nutrients, ions, and gases necessary for epithelial cell function.

Mechanism of Action

  • Protective barrier:

    Gastric mucin forms a thick, viscoelastic gel that coats the gastric epithelium, serving as the first line of defense against gastric acid and digestive enzymes, such as pepsin. This barrier minimizes direct contact between the epithelium and harmful luminal contents, preventing acid-induced tissue damage, proteolytic degradation, and mechanical abrasion from food particles. Its gel-like consistency also helps trap particles and facilitates their clearance.

  • Glycan-mediated interaction:

    The dense array of O-linked glycans on mucin’s protein backbone provides a structural and functional interface for interacting with both microorganisms and immune factors. These glycans serve as ligands for bacterial adhesins, notably those from Helicobacter pylori, which exploit specific sugar motifs to anchor onto gastric mucosa. Additionally, mucin glycans can modulate immune responses by engaging lectins and pattern recognition receptors, thus playing a role in immune surveillance and tolerance.

  • Hydration and gelation:

    Gastric mucins are highly hydrophilic due to their glycosylation, enabling them to absorb and retain large amounts of water, which is essential for forming a hydrated gel matrix. This gelation is further stabilized by intermolecular disulfide bonds between mucin monomers, creating a cross-linked network that maintains mucus integrity under the mechanical stress of peristalsis and gastric motility. This hydrated gel also facilitates the lubrication of gastric contents, aiding digestion and preventing mucosal friction.

  • pH-responsive behavior:

    The physicochemical properties of mucin, including its conformation, charge distribution, and viscosity, change dynamically with pH. In the highly acidic environment of the stomach lumen (pH ~1.5–3), mucins tend to form tighter, more compact gels, enhancing their barrier function. Closer to the epithelium where the pH is near neutral, mucins adopt a more expanded and relaxed conformation, enabling selective diffusion of nutrients and drugs while still restricting acid and protease penetration. This pH-sensitive behavior is crucial for maintaining a functional mucosal gradient and supporting the stomach’s dual roles in digestion and protection.

Applications in Scientific Research

  1. Drug delivery studies:
    • Gastric mucin is widely used to mimic the gastric mucus layer in vitro, allowing researchers to assess how well drugs, especially orally administered compounds, penetrate through the mucus barrier.
    • Mucin is used to test and optimize mucoadhesive drug delivery systems, such as nanoparticles, liposomes, and hydrogels, designed to prolong gastric residence time and enhance localized drug release. The interaction between nanoparticle surfaces and mucin glycoproteins is studied to identify materials that can effectively bind to the mucus layer without being prematurely cleared by peristalsis or mucus turnover.
  2. Microbiological and infectious disease research:
    • Studying adhesion mechanisms of Helicobacter pylori and other gastric pathogens: Gastric mucin plays a critical role in understanding how pathogens like H. pylori navigate and colonize the stomach lining. It provides a native-like glycan environment for studying bacterial adhesins (e.g., BabA, SabA), enabling researchers to decipher the specific carbohydrate structures that mediate bacterial attachment and to develop strategies for inhibiting adhesion and infection.
    • Due to its viscoelastic nature, mucin is used to simulate the physical properties of native mucus, allowing researchers to track and quantify how bacteria move through this complex environment. Such studies help elucidate flagella-mediated motility, chemotaxis, and the role of mucus viscosity in pathogen mobility and persistence in the stomach.
  3. Gastrointestinal physiology:
    • By studying isolated gastric mucin or using it as a component in ex vivo and in vitro models, researchers can investigate how mucins are synthesized, secreted, and regulated under physiological and pathological conditions. This research enhances our understanding of host defense mechanisms, particularly how mucin secretion responds to injury, infection, inflammation, and dietary stimuli.
    • Alterations in mucin expression, glycosylation, and secretion are closely associated with various gastric diseases. Studies using purified gastric mucin help in exploring how mucin composition changes during chronic gastritis, peptic ulcer disease, intestinal metaplasia, and gastric carcinoma. These insights contribute to the identification of biomarkers and therapeutic targets for gastrointestinal disorders.
  4. Biomaterials testing:
    • Used in in vitro testing of biosensors, scaffolds, and coatings for mucus interaction: Gastric mucin is utilized to evaluate how medical devices, implants, or biosensor surfaces interact with mucus-like environments. This includes assessing non-fouling properties, biocompatibility, and mucosal adhesion, especially for devices intended for gastrointestinal applications. Testing with mucin helps refine surface modifications (e.g. PEGylation, zwitterionic coatings) to minimize biofouling and immune activation.
  5. Enzymology and glycobiology:
    • Used to study mucin glycosylation patterns, mucin-degrading enzymes (e.g. mucinases). Gastric mucin serves as a biological substrate for investigating glycan structures, enzymatic glycosylation pathways, and glycosidase activity. It is commonly used to identify and characterize bacterial mucinases, which degrade the mucin network during infection, and to study the specificity and kinetics of host and microbial enzymes involved in mucin metabolism. These studies are crucial for understanding host-microbe interactions and gut homeostasis.

Packaging & Storage

  • Sources: purified from porcine stomach
  • Available as white to slightly yellow lyophilized powder
  • Store in an airtight container in a cool and dry place

References

  1. Corfield AP. 2015: Mucins: a biologically relevant glycan barrier in mucosal protection, Biochim Biophys Acta. 1850(1): 236-52.
  2. McGuckin MA, et al. 2011: Mucin dynamics and enteric pathogens, Nat Rev Microbiol. 9(4): 265-78.
  3. Corfield AP, et al. 2001: Mucins in the gastrointestinal tract in health and disease, Front Biosci. 6: D1321-57.
  4. Lee S, et al. 2005: Porcine gastric mucin (PGM) at the water/poly(dimethylsiloxane) (PDMS) interface: Influence of pH and ionic strength on its conformation, adsorption, and aqueous lubrication properties, Langmuir. 21(18): 8344-53.
  5. Hoffmann W. 2015: TFF2, a MUC6-binding lectin stabilizing the gastric mucus barrier and more (Review), Int J Oncol. 47(3): 806-16.
  6. Benson KK, et al. 2023: Understanding the clinical significance of MUC5AC in biliary tract cancers, Cancers (Basel). 15(2): 433.
  7. Dekker J, et al. 1991: The oligomeric structure of rat and human gastric mucins, Biochem J. 277(Pt 2): 423-7.
  8. Bara J, et al. 1998: Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene, Int J Cancer. 75(5): 767-73.
  9. Nordman H, et al. 1998: Mucus glycoproteins from pig gastric mucosa: different mucins are produced by the surface epithelium and the glands, Biochem J. 331(Pt 3): 687-94.
  10. Van den Brink GR, et al. 2000: H. pylori colocalises with MUC5AC in the human stomach, Gut. 46(5): 601-7.
  11. Hoffmann W. 2020: Trefoil factor family (TFF) peptides and their diverse molecular functions in mucus barrier protection and more: Changing the paradigm, Int J Mol Sci. 21(12): 4535.
  12. Niv Y. 2015: Helicobacter pylori and gastric mucin expression: A systematic review and meta-analysis, World J Gastroenterol. 21(31): 9430-6.
  13. Jessberger N, et al. 2019: Porcine gastric mucin triggers toxin production of enteropathogenic Bacillus cereus, Infect Immun. 87(4).
  14. Santos L, Lindén SK. 2025: Mucins as inhibitors against bacterial adhesion to epithelial cells, Methods Mol Biol. 2942: 45-53.
  15. Arai J, et al. 2024: The role of gastric mucins and mucin-related glycans in gastric cancers, Cancer Sci. 115(9): 2853-61.
  16. Kobayashi M, et al. 2009: Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection, Glycobiology. 19(5): 453-61.
  17. Tamura M, et al. 2020: Potential interaction between Galectin-2 and MUC5AC in mouse gastric mucus, Biol Pharm Bull. 43(2): 356-60.
  18. Dam TK, et al. 2022: Mechanism of mucin recognition by lectins: A thermodynamic study, Methods Mol Biol. 2442: 169-85.
  19. Kétyi I. 1990: Binding of enteric bacteria to hog gastric mucin, Acta Microbiol Hung. 37(1): 45-53.
  20. Smith H. 1950: Virulence-enhancing factor of hog gastric mucin, Nature. 165: 77.
  21. Libao-Mercado AJ, de Lange CFM. 2007: Refined methodology to purify mucins from pig colonic mucosa, Livestock Sci. 109(1–3): 141-4.
  22. Veronika J, et al. 2016: An optimized purification process for porcine gastric mucin with preservation of its native functional properties, RSC Adv. 6: 44932-43.

Jiagen Biotechnologies supplies quality Gastric Mucin of various specifications.
Contact us at sales@jiagen.ca to place an order.

Order